253 related articles for article (PubMed ID: 25893346)
1. Successful Total En Bloc Spondylectomy of T7 Vertebra for Hepatocellular Carcinoma Metastasis After Living Donor Liver Transplantation.
Kimura H; Fujibayashi S; Shimizu T; Otsuki B; Murakami H; Kaido T; Uemoto S; Matsuda S
Spine (Phila Pa 1976); 2015 Aug; 40(16):E944-7. PubMed ID: 25893346
[TBL] [Abstract][Full Text] [Related]
2. En Bloc lumpectomy of T12 vertebra for progressive hepatocellular carcinoma metastases following liver transplantation: A case report.
Hu JG; Lu Y; Lin XJ
Medicine (Baltimore); 2020 Jan; 99(2):e18756. PubMed ID: 31914098
[TBL] [Abstract][Full Text] [Related]
3. Thoracic vertebral metastasis from progressive hepatocellular carcinoma following liver transplantation combined with resection of mesenteric and colonic metastases: A case report.
Hu J; Hu C
Medicine (Baltimore); 2020 Oct; 99(44):e22937. PubMed ID: 33126359
[TBL] [Abstract][Full Text] [Related]
4. Total en bloc spondylectomy for lung cancer metastasis to the spine.
Murakami H; Kawahara N; Demura S; Kato S; Yoshioka K; Tomita K
J Neurosurg Spine; 2010 Oct; 13(4):414-7. PubMed ID: 20887137
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of hepatocellular carcinoma beyond Milan criteria. Results of liver resection, salvage transplantation, and primary liver transplantation.
Facciuto ME; Koneru B; Rocca JP; Wolf DC; Kim-Schluger L; Visintainer P; Klein KM; Chun H; Marvin M; Rozenblit G; Rodriguez-Davalos M; Sheiner PA
Ann Surg Oncol; 2008 May; 15(5):1383-91. PubMed ID: 18320284
[TBL] [Abstract][Full Text] [Related]
6. Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma.
An HJ; Jang JW; Bae SH; Choi JY; Yoon SK; Lee MA; You YK; Kim DG; Jung ES
Liver Transpl; 2012 Dec; 18(12):1406-14. PubMed ID: 22821639
[TBL] [Abstract][Full Text] [Related]
7. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma.
Taketomi A; Soejima Y; Yoshizumi T; Uchiyama H; Yamashita Y; Maehara Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):124-30. PubMed ID: 18392704
[TBL] [Abstract][Full Text] [Related]
9. Developments in liver transplantation for hepatocellular carcinoma.
Melloul E; Lesurtel M; Carr BI; Clavien PA
Semin Oncol; 2012 Aug; 39(4):510-21. PubMed ID: 22846868
[TBL] [Abstract][Full Text] [Related]
10. [A long-term survival case of hepatocellular carcinoma recurrence after the patient received a living donor liver transplantation treated by combined modality therapy].
Hama N; Marubashi S; Dono K; Kobayashi S; Kim C; Asaoka T; Takeda Y; Nagano H; Umeshita K; Monden M; Doki Y; Mori M
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2092-5. PubMed ID: 19106534
[TBL] [Abstract][Full Text] [Related]
11. Radiofrequency ablation therapy for bone metastasis from hepatocellular carcinoma: case report.
Maruyama M; Asano T; Kenmochi T; Kainuma O; Iwasaki K; Miyauchi H; Saigo K; Miura F; Kobayashi S; Ochiai T
Anticancer Res; 2003; 23(3C):2987-9. PubMed ID: 12926150
[TBL] [Abstract][Full Text] [Related]
12. Total En Bloc Spondylectomy for Solitary Metastatic Tumors of the Fourth Lumbar Spine in a Posterior-Only Approach.
Huang W; Wei H; Cai W; Xu W; Yang X; Liu T; Wu Z; Huang Q; Yan W; Xiao J
World Neurosurg; 2018 Dec; 120():e8-e16. PubMed ID: 29990608
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
14. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
15. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
16. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?
Adam R; Azoulay D; Castaing D; Eshkenazy R; Pascal G; Hashizume K; Samuel D; Bismuth H
Ann Surg; 2003 Oct; 238(4):508-18; discussion 518-9. PubMed ID: 14530722
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
18. Section 2. Small-for-size liver graft and hepatocellular carcinoma recurrence.
Chan SC
Transplantation; 2014 Apr; 97 Suppl 8():S7-S10. PubMed ID: 24849840
[TBL] [Abstract][Full Text] [Related]
19. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.
Margarit C; Escartín A; Castells L; Vargas V; Allende E; Bilbao I
Liver Transpl; 2005 Oct; 11(10):1242-51. PubMed ID: 16184539
[TBL] [Abstract][Full Text] [Related]
20. [A bone metastasis of hepatocellular carcinoma].
Nishimori T; Sakazaki S; Park I; Kawaguchi M; Nishigami T
Gan No Rinsho; 1990 Jul; 36(8):919-23. PubMed ID: 1694902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
